Teva���s U.S. Generic-Drug Sales Tumbled on Manufacturing Problem

profit doesn���t meet generally accepted accounting principles because it excludes costs linked to acquisitions. Net income under GAAP standards rose to $761 million in the quarter from $713 million a year earlier. --Editors: Phil Serafino, Marthe...